ivabradine has been researched along with 3-nitropropionic acid in 1 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (3-nitropropionic acid) | Trials (3-nitropropionic acid) | Recent Studies (post-2010) (3-nitropropionic acid) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 970 | 1 | 327 |
| Protein | Taxonomy | ivabradine (IC50) | 3-nitropropionic acid (IC50) |
|---|---|---|---|
| Isocitrate lyase | Candida albicans | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelkader, NF; Ahmed, MAE; Elbadawy, NN; Saad, MA | 1 |
1 other study(ies) available for ivabradine and 3-nitropropionic acid
| Article | Year |
|---|---|
Nano-ivabradine averts behavioral anomalies in Huntington's disease rat model via modulating Rhes/m-tor pathway.
Topics: Animals; Autophagy; Cardiovascular Agents; Corpus Striatum; Disease Models, Animal; Huntington Disease; Ivabradine; Male; Nanoparticle Drug Delivery System; Neuroprotective Agents; Nitro Compounds; Propionates; Rats; TOR Serine-Threonine Kinases | 2021 |